We aimed to assess whether subcutaneous lignocaine affects the success rate of intravenous cannulation using a randomized clinical trial. Pre-prepared cannulation packs, 50% containing local anaesthetic, were used to cannulate consecutive consenting patients presenting to the Emergency Department who required cannulation as part of their routine treatment. Doctors with less than four years postgraduate experience randomly selected a pack to perform cannulation and completed a data collection form after each cannulation.
Intravenous cannulation is one of the most common invasive procedures performed by junior hospital doctors. While local anaesthesia (LA) has been shown to reduce the pain of cannulation, even for small gauge cannulae 1 , a pre-study survey of 30 junior doctors at our institution showed that the majority did not use LA, believing it made no difference to pain and increased the degree of difficulty of the procedure. Previous research has shown that doctors did change their clinical practice when they were made aware that LA reduces the pain of cannulation 2 . The purpose of this study was to assess whether the use of LA affected the success rate of intravenous (IV) cannulation in an adult population. One previous study demonstrated the use of subcutaneous lignocaine did not affect the success rate of venous access in children under two years of age 3 . A literature search of the past 20 years showed little such data in the adult population.
MATERIALS AND METHODS

Setting and Participants
The study was conducted in the Emergency Department (ED) of a university-affiliated teaching hospital with an annual ED attendance of 40,000 patients. Subjects were recruited from consecutive consenting patients seen in the ED who required IV cannulation in the course of their medical care. Patients under 18 years of age, in need of urgent resuscitation or with a known allergy to LA were excluded. Cannulations were performed by junior doctors with less than four years postgraduate experience during their compulsory ED rotation. This study was approved by the Ethics Committee of the hospital.
Study Design
Two hundred cannulation kits containing both 16 gauge and 18 gauge cannulas, 100 with LA and a 100 without LA, were prepared prior to the commencement of the study. Kits with and without LA were externally indistinguishable from each other. Participating doctors about to perform IV cannulation randomly selected a kit after obtaining consent from the patient. The size of the cannula used was dependent upon the clinical requirement. Patients randomized to the LA group received 0.25 ml of 1% lignocaine subcutaneously via a 25 gauge needle. After the procedure, the doctor was required to complete a data collection form.
Data Analysis
The outcome was success or failure at the first cannulation attempt. Data was analysed using logistic regression 4, 5 . Potential confounders tested in the model were gauge of the cannula and the age and the gender of subjects.
RESULTS
A total of 166 patients were enrolled over a threeweek period. Eighty-seven subjects were enrolled in the LA group and 79 in the no LA group. Table 1 summarizes the results of the two groups. There was no statistically significant difference in the likelihood of successful cannulation between the LA and no LA groups (P=0.5). The results of the logistic regression analysis are shown in Table 2 . However, there was a statistically significant increase in success rate in the subgroup of age greater than 70 years and in the subgroup of males. The final logistic regression model explained only 5.6% of the total variance. Gauge as a confounder was excluded from the analysis as it did not significantly affect the variance in the model.
DISCUSSION
Subcutaneous lignocaine was chosen as it has been shown to significantly reduce the pain of venous cannulation 16 . The technique of administration is easy to teach and familiar to most medical practitioners. Despite evidence that LA reduces the pain of cannulation, many junior doctors are unaware of this 2 and believe that LA makes cannulation more difficult.
Our results showed that the use of LA did not significantly affect the likelihood of successful cannulation at the first attempt. The sample size was based on a power analysis which showed approximately 170 subjects would be required for the study to have an 80% chance of detecting a real difference of 25% in the success rate between the two groups. The power estimate was based on a large difference between the two groups, and although the differences in this study were not statistically significant, there was a trend towards a higher success rate in the LA group. The differences in the likelihood of successful cannulation between age and gender groups is consistent with the authors' experience. The final model accounted for 5.6% of the total variance in outcome; successful cannulation was primarily determined by factors which were outside the design of this study.
There are potential disadvantages associated with the use of LA. The risk of needlestick injury has been shown to be directly related to sharps exposure 7 . As subcutaneous LA requires the use of an extra needle, it theoretically increases the risk of needlestick injury. The use of LA involves the use of other items such as syringes and needles and their associated costs. The disposal of these extra items will also have an environmental impact. Adverse reactions to subcutaneous lignocaine, while rare 8 , may still occur.
Local anaesthesia has been shown to be effective in reducing the pain of venous cannulation without reducing the success rate. The results of this study support the use of LA for all routine venous cannulation. Previous research has shown that dissemination of such information to medical staff is essential to effect a change in clinical practice. 
